The global blood industry

The Global Blood Industry

The global sales of blood products reached $31.8 billion in 2015 and $33.5 billion in 2016.

The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.9% from 2016 to 2021, reaching nearly $42.6 billion in 2021.

Study Goals and Objectives The goals of this study on the blood industry are to describe and analyze the current markets for blood products, blood tests and blood-processing equipment, as well as present important new developments affecting every aspect of this industry. In addition, the report provides an analysis of market-value forecast through 2021 in constant dollars, as well as profiles of companies in the industry. The study covers the major aspects of blood and plasma collection/transfusion, including autologous donations, apheresis, fractionation, blood salvage and stem cells. The major plasma products such as coagulation factors, human serum albumin and immunoglobulins are analyzed as well. The scope and character of the blood-testing segment is changing constantly so the impact of new products, technologies and equipment is analyzed.

A safe and adequate blood supply is essential to the practice of modern medicine. The U.S. blood industry is safe and blood supplies are usually adequate. Current efforts in the industry are focused on increasing the blood supply in other world markets and improving education efforts for a safe and sufficient blood supply globally. New advances, particularly in the area of automation, have enhanced both safety and blood availability, and it is the purpose of this study to detail these advances and their impact on the blood industry. There have been advances in technology that have allowed more red blood cells to be obtained from fewer donors. Technological advances have also allowed for greater economies and increased safety in the blood supply.

Contribution of the Study and Intended Audience With its broad scope and in-depth analyses, this study will prove to be a valuable resource to anyone involved with or interested in the blood industry. This study will provide information on these areas:        

The structure and current market size of the blood industry with forecasts through 2021.

Blood-usage patterns and trends.

Government and regulatory controls.

The impact of disease on the blood industry.

Major players and their relative market share and market potential.

Current product lines and examination of newly emerging products and technologies.

The state of the international markets for various blood and blood-related products.

Newly issued patents relating to blood- and disease-screening technologies.

Since the study provides business and technical information of a timely nature, it will prove valuable to a variety of readers, including industry executives, managers and planners, researchers, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with the necessary data and information for careful decision-making.

This study encompasses the wide range of products and services that comprise the global blood-industry marketplace. The U.S. market, the largest in the world, provides the primary market breakdown with supplemental information given for other regions. The focus of the report is two-fold: first, blood for donation and the components and derived products from this blood and plasma, and second, products used to provide and support collection, processing and transfusion. Excluded from consideration are the clinical blood tests for diseases and conditions not involved in managing blood and plasma products.

Contact us at Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: poonam@bharatbook.com Our Blog: https://www.bharatbook.com/blog/ Twitter: https://twitter.com/researchbook Facebook: https://www.facebook.com/BharatBook3B LinkedIn: http://www.linkedin.com/company/bharat-book-bureau

THANK YOU